CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease in Subjects Who Completed CYS-004
Clinical trial NCT04523142 · COMPLETED
Trial details
- NCT number
- NCT04523142
- Sponsor
- Novaliq GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-04
- Primary completion
- 2022-04-30
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.